Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers
在健康志愿者中,对新型β-内酰胺酶抑制剂那库巴坦单独使用及与美罗培南联合使用时的安全性和药代动力学特征进行研究
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.02229-19
Mallalieu, Navita L; Winter, Erica; Fettner, Scott; Patel, Katie; Zwanziger, Elke; Attley, Gemma; Rodriguez, Ignacio; Kano, Akiko; Salama, Sameeh M; Bentley, Darren; Geretti, Anna Maria